Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPEN-IT: OPEN Versus InTact Capsule PPIs for Marginal Ulcers After Bariatric Surgery
NCT05799105Phase 4Recruiting
- Start
- Mar 2023
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of omeprazole in Marginal ulcer (2 arms). Primary endpoint: Ulcer healing at 12 months. Started Mar 2023; status: recruiting.
02
Drugs
omeprazole
03
Conditions
Marginal ulcer
Beyond the preview
Go deeper on NCT05799105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05799105.